Company news
Peptidream Inc. news in 2026
Peptidream Inc.'s news releases, calls and decks from 2026, newest first.
PeptiDream Announces Achievement of Development Milestone in Collaboration with MSD
October 7, 2026
Consolidated Financial Results for the Six Months Ended June 30, 2026 [IFRS]
August 12, 2026
Initiation of Phase 1 Clinical Trial by Novartis Marks Milestone for PeptiDream
August 11, 2026
PeptiDream Strengthens Leadership Team with Multiple Key Executive Appointments
July 2, 2026
PeptiDream Announces First Dosing of Claudin18.2 Targeting Radiopharmaceutical Candidate 64Cu-PD-29875 in Patients with Gastric Cancer
June 11, 2026
PeptiDream, PDRadiopharma and Curium Group Announce Completion of Patient Dosing in Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan
June 11, 2026
PeptiDream Announces the Initiation of Phase 1 Clinical Trial by Its Collaboration Partner
April 20, 2026